Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
ENvue Medical Moves NanoVibronix Manufacturing to the United States, Consolidates R&D in Tel Aviv, Israel, Increasing Operational Efficiencies and Cost Reduction Opportunities
GlobeNewswire, Inc.
TYLER, Texas, Aug. 04, 2026 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (NASDAQ: FEED) (“ENvue” or the “Company”), a commercial-stage medical device company, today announced it has completed the transition of its NanoVibronix manufacturing operations...
Sofwave Medical Reports Second Quarter and First Half 2026 Financial Results and Business Highlights
GlobeNewswire, Inc.
Second quarter revenue of $30M, +43% year-over-year growth; IFRS gross margin of 76.5% Second quarter usage fee revenue of $13.9M, 52.2% year-over-year growth First half revenue of $54.4M, +44% year-over-year growth; IFRS gross margin of 75.8%...
Entera Bio Phase 2 Data Supporting EB613’s (Oral PTH(1-34)) Anabolic Effect on Postmenopausal Women with Osteoporosis at High Risk for Fracture Selected for Plenary Poster Session Presentation at the ASBMR 2026 Annual Meeting
GlobeNewswire, Inc.
TEL AVIV, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX) (“Entera” or the “Company”), a leader in the development of oral peptides, today announced that post-hoc data from its Phase 2 clinical trial of EB613 (oral PTH(1-34)...
C2A Security Appoints Automotive and Product Security Leader and ASRG Founder John Heldreth to Advance Product Strategy
EIN Presswire
John brings extensive automotive, OEM, and cybersecurity leadership experience from companies like Porsche, Volkswagen, and Rivian to help shape C2A’s roadmap JERUSALEM, ISRAEL, August 4, 2026 /EINPresswire.com/ -- C2A Security, the context and...
Medasense Biometrics Receives Innovative Technology Contract from Vizient® for PMD-200™ with NOL Technology
EIN Presswire
Contract awarded for products that bring potential improvement to healthcare industry.
Silexion Therapeutics Reports New Positive Preclinical Findings Demonstrating Multi-Mechanism Immune Sensitization by SIL204 in KRAS-Driven Cancers
GlobeNewswire, Inc.
New preclinical data demonstrate that SIL204 treatment produced statistically significant upregulation of FAS (CD95), the immune “death receptor,” and statistically significant downregulation of HLA-G, an established immune checkpoint, in human...
Enlight Renewable Energy Reports Second Quarter 2026 Financial Results
GlobeNewswire, Inc.
All of the amounts disclosed in this press release are in U.S. dollars unless otherwise noted TEL AVIV, Israel, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Enlight Renewable Energy (NASDAQ: ENLT, TASE: ENLT) today reported financial results for the quarter...
Silexion Therapeutics Successfully Initiates Phase 2/3 Clinical Trial of SIL204 in Locally Advanced Pancreatic Cancer at Tel Aviv Sourasky Medical Center
GlobeNewswire, Inc.
Successful initiation of the Phase 2/3 clinical trial of SIL204 at Tel Aviv Sourasky Medical Center (“TASMC” or “Ichilov”), one of Israel’s largest and most prominent academic medical centers, clears the site to commence patient screening...
Influential Women Features LaSandra Boykin: Corporate Social Impact Executive Building Stronger Communities
EIN Presswire
JACKSONVILLE, FL, UNITED STATES, August 4, 2026 /EINPresswire.com/ -- With More Than 20 Years of Experience Across Transportation and Healthcare Industries, LaSandra Boykin Continues to Build Meaningful Connections, Empower Communities, and...
Tower Semiconductor Announces Record Results for Revenue and Profitability for the Second Quarter 2026 with Third Quarter 2026 Record Revenue Guidance
GlobeNewswire, Inc.
$460 million second quarter revenue, 24% year-over-year growth; Guiding third quarter revenue of $520 million, 31% year-over-year growth MIGDAL HAEMEK, Israel, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Tower Semiconductor (NASDAQ/TASE: TSEM) reports today...
Merit Medical Reports Second Quarter 2026 Results And Updates Full-Year 2026 Guidance
GlobeNewswire, Inc.
Financial Highlights† Reported revenue of $418.8 million, up 10% Constant currency revenue* and constant currency revenue, organic* up 9% and up 9%, respectively GAAP operating margin of 14.4%, compared to 12.3% in prior year period Non-GAAP...
More Startups are Arriving with Working Products, but Fewer are Managing to Raise Capital
EIN Presswire
Registration opens for MerageNext: Up to $100,000 grant, participation in Merage exclusive program in California, and Microsoft for Startups support ISRAEL, August 4, 2026 /EINPresswire.com/ -- Despite a significant recovery in fundraising...
Assured Raises $19M Series A Led by Insight Partners to Automate Healthcare Provider Operations with AI Agents
GlobeNewswire, Inc.
NEW YORK, July 30, 2026 (GLOBE NEWSWIRE) -- This funding accelerates Assured’s mission to replace manual healthcare provider operations with AI agents, so providers get onboarded faster and patients receive care sooner.
UroGen Pharma to Report Second Quarter 2026 Financial Results on Wednesday, August 5th, 2026
GlobeNewswire, Inc.
PRINCETON, N.J., July 29, 2026 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that it will...
123rd Medical Group and Kentucky Guard Airmen honored for national excellence
DVIDS - Georgia
The Kentucky Air National Guard’s 123rd Medical Group has been named Air National Guard Medical Unit of the Year, and two of its officers have been recognized for individual excellence in the 2025 Air National Guard Medical Service Awards.
Nasus Pharma Appoints Pharmaceutical Industry Veteran Brendan P. O'Grady as Chief Executive Officer to Lead Strategic Growth
GlobeNewswire, Inc.
TEL AVIV, Israel, July 28, 2026 (GLOBE NEWSWIRE) -- Nasus Pharma Ltd. (NYSE: NSRX) ("Nasus", “Nasus Pharma” or the "Company"), a clinical-stage pharmaceutical company focused on the development of innovative intranasal products, today announced...
Sheba Medical Center Collaborates with OpenAI on Its First International Healthcare Deployment
EIN Presswire
A Major Step in the Hospital’s AI Transformation, Collaboration Will Provide Clinicians with OpenAI's Most Advanced Clinical Reasoning Platform RAMAT GAN, ISRAEL, July 28, 2026 /EINPresswire.com/ -- Sheba Medical Center announced today a...
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Agios Pharmaceuticals, Inc. - AGIO
GlobeNewswire, Inc.
NEW YORK, July 28, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Agios Pharmaceuticals, Inc. (“Agios” or the “Company”) (NASDAQ: AGIO). Such investors are advised to contact Danielle Peyton at...
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HCA Healthcare, Inc. - HCA
GlobeNewswire, Inc.
NEW YORK, July 28, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of HCA Healthcare, Inc. (“HCA” or the “Company”) (NYSE: HCA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or...
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ionis Pharmaceuticals, Inc. - IONS
GlobeNewswire, Inc.
NEW YORK, July 28, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Ionis Pharmaceuticals, Inc. (“Ionis” or the “Company”) (NASDAQ: IONS). Such investors are advised to contact Danielle Peyton at...
Sign up for:
Israel Healthcare News
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.